Activation of natural killer T cells by α-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi

Infection and Immunity

Volumn 71, Issue 3, 2003, Pages 1234-1241

  Miyahira, Yasushi ^a   Katae, Masaharu ^a   Takeda, Kazuyoshi ^a   Yagita, Hideo ^a   Okumura, Ko ^a   Kobayashi, Seiki ^b   Takeuchi, Tsutomu ^b   Kamiyama, Tsuneo ^c   Fukuchi, Yoshinosuke ^a   Aoki, Takashi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; GALACTOSYLCERAMIDE; TOLAZOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HOST SUSCEPTIBILITY; IMMUNE RESPONSE; IMMUNITY; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE; TRYPANOSOMA CRUZI; VACCINATION; WILD TYPE;

ANIMALS; ANTIGENS, CD1; CD8-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; FEMALE; GALACTOSYLCERAMIDES; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTOZOAN VACCINES; TRYPANOSOMA CRUZI; VACCINES, DNA;

EID: 0037371320     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.3.1234-1241.2003     Document Type: Article

References (48)

1. + T-cell homeostasis by perforin and interferon-γ. Science 290:1354-1358.
2. Biron, C. A., and L. Brossay. 2001. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13:458-464.
3. Brener, Z., and R. T. Gazzinelli. 1997. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 114:103-110.
4. Burdin, N., L. Brossay, and M. Kronenberg. 1999. Immunization with a-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29:2014-2025.
5. Cardillo, F., J. C. Voltarelli, S. G. Reed, and J. S. Silva. 1996. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect. Immun. 64:128-134.
6. + T cell responses. J. Immunol. Methods 252:207-218.
7. + T-cell responses against malaria liver stages. Nat. Med. 8:166-170.
8. Chagas, C. 1909. Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., agente etiolojico de nova entidade morbida do homem. Mem. Inst. Oswaldo Cruz 1:159-218.
9. Chen, L., T. Watanabe, H. Watanabe, and F. Sendo. 2001. Neutrophil depletion exacerbates experimental Chagas' disease in BALB/c, but protects C57BL/6 mice through modulating the Th1/Th2 dichotomy in different directions. Eur. J. Immunol. 31:265-275.
10. DosReis, G. A. 1997. Cell-mediated immunity in experimental Trypanosoma cruzi infection. Parasitol. Today 13:335-342.
11. Duthie, M. S., M. Wieklinski-Lee, S. Smith, T. Nakayama, M. Taniguchi, and S. J. Kahn. 2002. During Trypanosoma cruzi infection CDld-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect. Immun. 70:36-48.
12. Duthie, M. S., and S. J. Kahn. 2002. Treatment with α-Galactosylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive. J. Immunol. 168:5778-5785.
13. Gonzalez-Aseguinolaza, G., C. de Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van Kaer, Y. Koezuka, and M. Tsuji. 2000. α-galactosylceramide-activated Vα 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97:8461-8466.
14. Gonzalez-Aseguinolaza, G., L. Van Kaer, C. C. Bergmann, J. M. Wilson, J. Schmieg, M. Kronenberg, T. Nakayama, M. Taniguchi, Y. Koezuka, and M. Tsuji. 2002. Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195:617-624.
15. Hayakawa, Y., K. Takeda, H. Yagita, S. Kakuta, Y. Iwakura, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide. Eur. J. Immunol. 31:1720-1727.
16. Horspool, J. H., P. J. Perrin, J. B. Woodcock, J. H. Cox, C. L. King, C. H. June, D. M. Harlan, D. C. St. Louis, and K. P. Lee. 1998. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4. J. Immunol. 160:2706-2714.
17. Hunter, C. A., T. Slifer, and F. Araujo. 1996. Interleukin-12 -mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infect. Immun. 64:2381-2386.
18. Kakimi, K., L. G. Guidotti, Y. Koezuka, and F. V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192:921-930.
19. Katae, M., Y. Miyahira, K. Takeda, H. Matsuda, H. Yagita, K. Okumura, T. Takeuchi, T. Kamiyama, A. Ohwada, Y. Fukuchi, and T. Aoki, 2002. Coadministration of interleukin-12 gene with a Trypanosoma cruzi gene improves vaccine efficacy. Infect. Immun. 70:4833-4840.
20. + natural killer T cells by a-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Infect. Immun. 69:6643-6650.
21. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, H. Sato, E. Kondo, M. Harada, H. Koseki, T. Nakayama, Y. Tanaka, and M. Taniguchi, 1998. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc. Natl. Acad. Sci. USA 95:5690-5693.
22. Kirchhoff, L. V. 1990. Trypanosoma species (American trypanosomiasis, Chagas disease): biology of trypanosomes, p. 2077-2084. In G. L. Mandell, R. G. Douglas, Jr., and J. E. Bennett (ed.), Principles and practice of infectious diseases, 3rd ed. Churchill Livingstone, New York, N.Y.
23. Kirchhoff, L. V. 1993. American trypanosomiasis (Chagas' disease): a tropical disease now in the United States. N. Engl. J. Med. 329:639-644.
24. Kitamura, H., K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, M. Taniguchi, and T. Nishimura. 1999. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189:1121-1128.
25. Kobayashi, E., K. Motoki, T. Uchida, H. Fukushima, and Y. Koezuka. 1995. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol. Res. 7:529-534.
26. Metelitsa, L. S., O. V. Naidenko, A. Kant, H. W. Wu, M. J. Loza, B. Perussia, M. Kronenberg, and R. C. Seeger. 2001. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol. 167:3114-3122.
27. Michailowsky, V., S. M. Murta, L. Carvalho-Oliveira, M. E. Pereira, L. R. Ferreira, Z. Brener, A. J. Romanha, and R. T. Gazzinelli, 1998. Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi. Antimicrob. Agents Chemother. 42:2549-2556.
28. Miyahira, Y., and J. A. Dvorak. 1994. Kinetoplastidae display naturally occurring ancillary DNA-containing structures. Mol. Biochem. Parasitol. 65: 339-349.
29. + T cells using an ELISPOT assay. J. Immunol. Methods 181:45-54.
30. + responses in mice. Proc. Natl. Acad. Sci. USA 95:3954-3959.
31. + T cell-mediated protective immunity against Trypanosoma cruzi. Int. Immunol. 11:133-141.
32. Moodyclife, A. M., D. Nghiem, G. Clydesdale, and S. E. Ulirich. 2000. Immune suppression and skin cancer development: regulation by NKT cells. Nat. Immunol. 1:521-525.
33. + T-cell responses induced by recombinant influenza and vaccinia viruses. Cell. Immunol. 173: 96-107.
34. Nishimura, T., H. Kitamura, K. Iwakabe, T. Yahata, A. Ohta, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, M. Taniguchi, M. Nakui, M. Sekimoto, and T. Koda. 2000. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12:987-994.
35. + T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus. Vaccine 17:1863-1869.
36. Prata, A. 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1:92-100.
37. Revelli, S., H. Davila, M. E. Ferro, M. Romero-Piffiguer, O. Musso, J. Valenti, J. Bernabo, E. Falcoff, J. Wietzerbin, and O. Bottasso. 1992. Acute and chronic experimental Trypanosoma cruzi infection in the rat: response to systemic treatment with recombinant rat interferon-gamma. Microbiol. Immunol. 39:275-281.
38. Rodriguez, M. M., M. Ribeirao, V. Pereira-Chioccola, L. Renia, and F. Costa. 1999. Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. Infect. Immun. 67:3855-3863.
39. Rottenberg, M. E., A. Riarte, L. Sorrong, J. Altcheh, P. Petray, A. M. Ruiz, and H. Wigzell. 1995. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Immunol. Lett. 45:53-60.
40. Smyth, M. J., and D. I. Godfrey. 2000. NKT cells and tumor immunity-a double-edged sword. Nat. Immunol. 1:459-460.
41. Smyth, M. J., N. Y. Crowe, Y. Hayakawa, K. Takeda, H. Yagita, and D. I. Godfrey. 2002. NKT cells-conductors of tumor immunity? Curr. Opin. Immunol. 14:165-171.
42. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99:1259-1266.
43. Sonoda, K. H., D. E. Faunce, M. Taniguchi, M. Exley, S. Balk, and J. Stein-Streilein. 2001. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166:42-50.
44. Suresh, M., J. K. Whitmire, L. E. Harrington, C. P. Larsen, T. C. Pearson, J. D. Altman, and R. Ahmed. 2001. Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J. Immunol. 167:5565-5573.
45. + T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 144:717-724.
46. 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356:338-340.
47. Tarleton, R. L., M. J. Grusby, M. Postan, and L. H. Glimcher. 1996. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol. 8:13-22.
48. Terabe, M., S. Matsui, N. Noben-Trauth, H. Chen, C. Watson, D. D. Donaldson, D. P. Carbone, W. E. Paul, and J. A. Berzofsky. 2000. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 1:515-520.